The Predict-TB network, funded by the EU Innovative Medicine Initiative, aims at discovering new therapies against tuberculosis, a disease that kills around 1.7 million people per year. Researchers participating in this consortium are providing their expertise in biology, immunology, imaging and pharmacokinetics focusing on drug development and aiming to develop assays that can lead to novel treatments of tuberculosis.
Visit website